Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107899611B details bifunctional catalysts combining cinchona alkaloids and porphyrins for visible-light driven asymmetric synthesis, offering greener pharmaceutical intermediate production.
Patent CN115850252A discloses a novel iron-iodine co-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN108129373B details a novel 3-step palladium-catalyzed route for diaryl pyrroles, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel radical reaction method for high-purity enaminone derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel copper-catalyzed route for 5,6-dihydrobenzo[c]acridine offers high atom economy and mild conditions for scalable pharmaceutical manufacturing.
Novel MOF-Cu catalyzed Ugi reaction for high-purity dipeptide intermediates. Cost-effective, scalable synthesis with reusable catalyst for pharmaceutical applications.
Patent CN111170847B reveals a cyanide-free route for Drotaverine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Novel nickel-catalyzed route for Flindokalner racemate offers safer, scalable production. Ideal for neuroprotective drug supply chains seeking cost efficiency.
Patent CN108440623A reveals a novel silylation-free route for Capecitabine Intermediate. Achieve higher purity and reduced manufacturing costs with scalable supply.
Novel continuous synthesis method for high-purity 3-methyl-3-butene-1-alcohol. Reduces pressure and temperature while enhancing supply chain reliability for global buyers.
Patent CN109761975B reveals a catalyst-free aminomethylation route for imidazoheteroaryls, offering significant cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed method converts tert-butyl isonitrile to amidines. Reduces costs and simplifies supply chain for pharmaceutical intermediate manufacturing.
Patent CN105273006B details a high-yield synthesis route for advanced ligands. This method ensures high purity and simplified processing for reliable pharmaceutical intermediates supply chains.
Patent CN104109174B introduces a novel ligand for asymmetric methoxycarbonylation, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply reliability.
Novel amide solvent method ensures high purity for Abemaciclib intermediate. Reduces impurities and simplifies supply chain for pharmaceutical manufacturing.
Patent CN114621128A reveals a novel TBS-protection strategy for (S)-oxiracetam, eliminating column chromatography to ensure >99.9% purity and significant cost reduction.
Patent CN101417910A details solid acid catalysis for prazole nitration, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed route for baloxavir intermediate. Safer, scalable, cost-effective manufacturing solution for global supply chains.
Novel palladium-catalyzed quinazolinone synthesis offers high yield and scalable production capabilities for global pharmaceutical intermediates manufacturing supply chains.
Novel one-pot synthesis for 2-arylaminoacetamide compounds reduces hazardous waste and improves safety for scalable pharmaceutical intermediate manufacturing supply chains.